Sujay Kumar Singh
About Sujay Kumar Singh
Sujay Kumar Singh has 23 years in corporate governance. Holds Director role. Currently with 3 companies, including Charak International Private Limited and Abgenex Private Limited. Formerly with 2 companies, such as Samik Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Abgenex Private Limited
U24239OR2002PTC006982
|
Director | 25 Nov 2002 | 2002 | Active |
Imgenex India Private Limited
U24239OR2004PTC007628
|
Director | 04 Jun 2004 | 2004 | Active |
Bio Entities Private Limited
U72100OR2009PTC011316
|
Director | 13 Nov 2009 | 2009 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Samik Pharmaceuticals Private Limited
U24230OR2011PTC014258
|
Director | 23 Sep 2011 | 2011 | Strike Off |
Charak International Private Limited
U24231OR2007PTC009349
|
Director | 11 Jun 2007 | 2007 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sujay Kumar Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sujay Kumar Singh
Sujay Kumar Singh has 23 years in corporate governance. Holds Director role. Currently with 3 companies, including Charak International Private Limited and Abgenex Private Limited. Formerly with 2 companies, such as Samik Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.
Sujay Kumar Singh is associated with 3 companies as Director.
Sujay Kumar Singh has expertise in General Business.
Sujay Kumar Singh has 23 years in corporate governance.